全文获取类型
收费全文 | 639篇 |
免费 | 45篇 |
专业分类
684篇 |
出版年
2024年 | 4篇 |
2023年 | 3篇 |
2022年 | 15篇 |
2021年 | 30篇 |
2020年 | 12篇 |
2019年 | 18篇 |
2018年 | 20篇 |
2017年 | 28篇 |
2016年 | 40篇 |
2015年 | 39篇 |
2014年 | 38篇 |
2013年 | 64篇 |
2012年 | 69篇 |
2011年 | 58篇 |
2010年 | 29篇 |
2009年 | 32篇 |
2008年 | 33篇 |
2007年 | 28篇 |
2006年 | 20篇 |
2005年 | 13篇 |
2004年 | 14篇 |
2003年 | 13篇 |
2002年 | 12篇 |
2001年 | 6篇 |
2000年 | 9篇 |
1999年 | 1篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1990年 | 4篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1973年 | 1篇 |
1956年 | 1篇 |
排序方式: 共有684条查询结果,搜索用时 5 毫秒
681.
Ghazally Ismail Nyonya Razak Rahmah Mohamed Noor Embi Othman Omar 《Microbiology and immunology》1988,32(7):645-652
The effect of human normal serum (HNS) on Pseudomonas pseudomallei was determined. It is apparent from our data that the organism is resistant to the normal serum bactericidal mechanism. Ancillary experiments to confirm this serum-resistant property of P. pseudomallei were done by examining the effects of growth phase conditions of the bacteria (i.e., logarithmic and stationary phases) and different buffered systems used as diluent in our bactericidal assay. Results obtained showed similar degree of resistance to serum bactericidal killing by 5 strains of the organisms tested. The possible survival advantage of serum-resistant property to P. pseudomallei as bacterial pathogens known to invade the blood stream is discussed. 相似文献
682.
Tengku Haziyamin Tengku Abdul Hamid Raja Noor Zaliha Raja Abd Rahman Abu Bakar Salleh Mahiran Basri 《The protein journal》2010,29(4):290-297
The use of lipase in hydrophilic solvent is usually hampered by inactivation. The solvent stability of a recombinant solvent
stable lipase isolated from thermostable Bacillus sp. strain 42 (Lip 42), in DMSO and methanol were studied at different solvent-water compositions. The enzymatic activities
were retained in up to 45% v/v solvent compositions. The near-UV CD spectra indicated that tertiary structures were perturbed
at 60% v/v and above. Far-UV CD in methanol indicated the secondary structure in Lip 42 was retained throughout all solvent
compositions. Fluorescence studies indicated formations of molten globules in solvent compositions of 60% v/v and above. The
enzyme was able to retain its secondary structures in the presence of methanol; however, there was a general reduction in
β-sheet and an increase in α-helix contents. The H-bonding arrangements triggered in methanol and DMSO, respectively, caused
different forms of tertiary structure perturbations on Lip 42, despite both showing partial denaturation with molten globule
formations. 相似文献
683.
A number of recent studies have implicated the angiotensinogen gene in the aetiology of essential hypertension in Caucasian,
Japanese and African Caribbean subjects. We have genotyped 153 healthy white Caucasian subjects at a dinucleotide repeat polymorphism
and seven diallelic sites in the coding or flanking regions of the angiotensinogen gene, including one polymorphism not previously
studied. We have also documented patterns of linkage disequilibrium between polymorphisms. There is evidence of variation
in the frequency of several mutations when compared with published results from other Caucasian control populations, possibly
due to cryptic ethnic differences between these groups. This should be considered in the design and interpretation of studies
of the angiotensinogen gene.
Received: 10 November 1995 / Revised: 25 March 1996 相似文献
684.
Guillaume Butler-Laporte Tomoko Nakanishi Vincent Mooser David R. Morrison Tala Abdullah Olumide Adeleye Noor Mamlouk Nofar Kimchi Zaman Afrasiabi Nardin Rezk Annarita Giliberti Alessandra Renieri Yiheng Chen Sirui Zhou Vincenzo Forgetta J. Brent Richards 《PLoS medicine》2021,18(6)
BackgroundIncreased vitamin D levels, as reflected by 25-hydroxy vitamin D (25OHD) measurements, have been proposed to protect against COVID-19 based on in vitro, observational, and ecological studies. However, vitamin D levels are associated with many confounding variables, and thus associations described to date may not be causal. Vitamin D Mendelian randomization (MR) studies have provided results that are concordant with large-scale vitamin D randomized trials. Here, we used 2-sample MR to assess evidence supporting a causal effect of circulating 25OHD levels on COVID-19 susceptibility and severity.Methods and findingsGenetic variants strongly associated with 25OHD levels in a genome-wide association study (GWAS) of 443,734 participants of European ancestry (including 401,460 from the UK Biobank) were used as instrumental variables. GWASs of COVID-19 susceptibility, hospitalization, and severe disease from the COVID-19 Host Genetics Initiative were used as outcome GWASs. These included up to 14,134 individuals with COVID-19, and up to 1,284,876 without COVID-19, from up to 11 countries. SARS-CoV-2 positivity was determined by laboratory testing or medical chart review. Population controls without COVID-19 were also included in the control groups for all outcomes, including hospitalization and severe disease. Analyses were restricted to individuals of European descent when possible. Using inverse-weighted MR, genetically increased 25OHD levels by 1 standard deviation on the logarithmic scale had no significant association with COVID-19 susceptibility (odds ratio [OR] = 0.95; 95% CI 0.84, 1.08; p = 0.44), hospitalization (OR = 1.09; 95% CI: 0.89, 1.33; p = 0.41), and severe disease (OR = 0.97; 95% CI: 0.77, 1.22; p = 0.77). We used an additional 6 meta-analytic methods, as well as conducting sensitivity analyses after removal of variants at risk of horizontal pleiotropy, and obtained similar results. These results may be limited by weak instrument bias in some analyses. Further, our results do not apply to individuals with vitamin D deficiency.ConclusionsIn this 2-sample MR study, we did not observe evidence to support an association between 25OHD levels and COVID-19 susceptibility, severity, or hospitalization. Hence, vitamin D supplementation as a means of protecting against worsened COVID-19 outcomes is not supported by genetic evidence. Other therapeutic or preventative avenues should be given higher priority for COVID-19 randomized controlled trials.In a Mendelian randomization analysis, Guillaume Butler-Laporte, Tomoki Nakanishi, and colleages study genetic evidence for a relationship between vitamin D and COVID-19 outcomes. 相似文献